Intra- and interspecies gene expression models for predicting drug response in canine osteosarcoma

• Published in: BMC bioinformatics 2016-02, Vol.17 (71), p.93-93, Article 93
• Main Authors: Fowles, Jared S, Brown, Kristen C, Hess, Ann M, Duval, Dawn L, Gustafson, Daniel L
• Format: Article
• Language: English
• Subjects: Animals; Anthracyclines; Biomarkers; Biomarkers, Pharmacological; Bone cancer; Bone Neoplasms - genetics; Breast cancer; Care and treatment; Clinical trials; Complications and side effects; Dog Diseases; Dogs; Doxorubicin; Gene expression; Gene Expression - genetics; Humans; Methods; Osteosarcoma; Osteosarcoma - genetics; Prognosis; Survival analysis; Treatment Outcome; Tumors; Veterinary medicine
• ISSN: 1471-2105; 1471-2105
• DOI: 10.1186/s12859-016-0942-8

Genomics-based predictors of drug response have the potential to improve outcomes associated with cancer therapy. Osteosarcoma (OS), the most common primary bone cancer in dogs, is commonly treated with adjuvant doxorubicin or carboplatin following amputation of the affected limb. We evaluated the use of gene-expression based models built in an intra- or interspecies manner to predict chemosensitivity and treatment outcome in canine OS. Models were built and evaluated using microarray gene expression and drug sensitivity data from human and canine cancer cell lines, and canine OS tumor datasets. The "COXEN" method was utilized to filter gene signatures between human and dog datasets based on strong co-expression patterns. Models were built using linear discriminant analysis via the misclassification penalized posterior algorithm. The best doxorubicin model involved genes identified in human lines that were co-expressed and trained on canine OS tumor data, which accurately predicted clinical outcome in 73 % of dogs (p = 0.0262, binomial). The best carboplatin model utilized canine lines for gene identification and model training, with canine OS tumor data for co-expression. Dogs whose treatment matched our predictions had significantly better clinical outcomes than those that didn't (p = 0.0006, Log Rank), and this predictor significantly associated with longer disease free intervals in a Cox multivariate analysis (hazard ratio = 0.3102, p = 0.0124). Our data show that intra- and interspecies gene expression models can successfully predict response in canine OS, which may improve outcome in dogs and serve as pre-clinical validation for similar methods in human cancer research.